2021 Biotech IPOs Get Off to a Roaring Start
The Pharma Data
JANUARY 19, 2021
It hopes to raise about $160 million in aggregate principal amount of 7.375% senior notes due 2025 and $270 million in aggregate principal amount of 7.250% senior notes due 2028. Ortho Clinical Diagnostics is a leader in in vitro diagnostics. It is offering 70 million ordinary shares with a price between $20 and $23 per share.
52 
Let's personalize your content